Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Fabio Fiorino, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
Laura Pérez‐Alós, José Juan Almagro Armenteros, Johannes Roth Madsen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 162
Understanding T cell responses to COVID-19 is essential for informing public health strategies
Santosha A. Vardhana, Lance Baldo, William G. Morice, et al.
Science Immunology (2022) Vol. 7, Iss. 71
Open Access | Times Cited: 118
Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2939-2961
Open Access | Times Cited: 116
Characterization of nanoparticles-based vaccines for COVID-19
Giuditta Guerrini, Davide Magrì, Sabrina Gioria, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 6, pp. 570-576
Open Access | Times Cited: 103
Adaptive Immune Responses and Immunity to SARS-CoV-2
Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 90
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
Overview of Neutralizing Antibodies and Their Potential in COVID-19
José Javier Morales‐Núñez, José Francisco Muñoz‐Valle, Paola Carolina Torres-Hernández, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1376-1376
Open Access | Times Cited: 67
Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration
Giuditta Guerrini, Sabrina Gioria, Aisha V. Sauer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8838-8838
Open Access | Times Cited: 52
Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS‐CoV‐2 infection*
Salma Sheikh‐Mohamed, Erin C. Sanders, Jennifer L. Gommerman, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 75-85
Open Access | Times Cited: 46
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
Maddy L. Newby, Carl A. Fogarty, Joel D. Allen, et al.
Journal of Molecular Biology (2022) Vol. 435, Iss. 4, pp. 167928-167928
Open Access | Times Cited: 44
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans
Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Science Immunology (2024) Vol. 9, Iss. 94
Open Access | Times Cited: 8
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, María Ruiz‐Ruigómez, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010211-e1010211
Open Access | Times Cited: 50
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19
Roberto Lozano‐Rodríguez, Jaime Valentín‐Quiroga, José Avendaño‐Ortiz, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110235-110235
Open Access | Times Cited: 46
Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
Athanasios‐Dimitrios Bakasis, Kleopatra Bitzogli, Dimitrios Mouziouras, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 207-207
Open Access | Times Cited: 36
Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
Patricia Almendro-Vázquez, Marta Chivite‐Lacaba, Alberto Utrero‐Rico, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
B lymphocytes in COVID-19: a tale of harmony and discordance
Amir Hossein Mansourabadi, Azin Aghamajidi, Maryam Dorfaki, et al.
Archives of Virology (2023) Vol. 168, Iss. 5
Open Access | Times Cited: 18
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
Jacopo Polvere, Massimiliano Fabbiani, G Pastore, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
Katharina Röltgen, Scott D. Boyd
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 69-97
Open Access | Times Cited: 15
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
G Pastore, Jacopo Polvere, Fabio Fiorino, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 432-444
Open Access | Times Cited: 5
Cellular Response, Persistent Humoral Response and Efficacy Elicited by a Cv-A16 Vaccine Candidate in Mice
Xuzhen Qin, Mi Deng, Jie Wu, et al.
(2025)
Closed Access
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses
Annalisa Ciabattini, Elena Pettini, Fabio Fiorino, et al.
EBioMedicine (2025) Vol. 113, pp. 105577-105577
Open Access
Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine
Xiuwen Wang, Xiaodong Yang, Xin Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top